Table 3 Allele combination frequencies of the four polymorphisms in athletes and control groups
From: Association of genome variations in the renin-angiotensin system with physical performance
ACE(I, D), LEP(G, A), BDKRB2(+9, −9), AGTR1(A, C) | Male controls | Male athletes | pvalue | Female controls | Female athletes | pvalue |
|---|---|---|---|---|---|---|
(n= 88) | (n= 102) | (n= 83) | (n= 73) | |||
IA+9A | 31 (35.22%) | 42 (41.2%) | 0.435 | 32 (38.6%) | 24 (32.9%) | 0.461 |
IG+9A | 36 (40.9%) | 45 (44.1%) | 0.705 | 43 (51.8%) | 24 (32.9%) | 0.017 |
IA−9A | 26 (29.54%) | 30 (29.4%) | 0.943 | 27 (32.5%) | 17 (23.3%) | 0.201 |
IG−9A | 28 (31.8%) | 38 (37.3%) | 0.466 | 35 (42.2%) | 15 (20.5%) | 0.004 |
IA+9C | 11 (12.5%) | 15 (14.7%) | 0.682 | 14 (16.9%) | 7 (9.6%) | 0.184 |
IG+9C | 15 (17%) | 20 (19.6%) | 0.676 | 20 (24.1%) | 11 (15.1%) | 0.159 |
IA−9C | 13 (14.77%) | 15 (14.7%) | 0.964 | 13 (15.7%) | 6 (8.2%) | 0.156 |
IG−9C | 15 (17%) | 20 (19.6%) | 0.676 | 15 (18.1%) | 6 (8.2%) | 0.072 |
DA+9A | 46 (52.27%) | 61 (59.8%) | 0.338 | 38 (45.8%) | 38 (52.1%) | 0.434 |
DG+9A | 50 (56.8%) | 65 (63.7%) | 0.380 | 49 (59%) | 39 (53.4%) | 0.481 |
DA−9A | 38 (43.2%) | 42 (41.2%) | 0.729 | 31 (37.3%) | 32 (43.8%) | 0.410 |
DG−9A | 38 (43.2%) | 53 (52%) | 0.256 | 44 (53%) | 31 (42.5%) | 0.188 |
DA+9C | 16 (18.18%) | 24 (23.5%) | 0.389 | 16 (19.3%) | 17 (23.3%) | 0.541 |
DG+9C | 18 (20.45%) | 31 (30.4%) | 0.129 | 24 (28.9%) | 25 (34.2%) | 0.474 |
DA−9C | 15 (17%) | 22 (21.6%) | 0.455 | 14 (16.9%) | 14 (19.2%) | 0.707 |
DG−9C | 16 (18.18%) | 28 (27.5%) | 0.142 | 20 (24.1%) | 18 (24.7%) | 0.935 |